The burgeoning family of unconventional T cells

Nature Immunology

Volumn 16, Issue 11, 2015, Pages 1114-1123

  Godfrey, Dale I ^a   Uldrich, Adam P ^a   Mccluskey, James ^a   Rossjohn, Jamie ^b,c   Moody, D Branch ^d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; CD1D ANTIGEN; HLA ANTIGEN CLASS 1; LYMPHOCYTE ANTIGEN RECEPTOR;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; GAMMA DELTA T LYMPHOCYTE; HUMAN; IMMUNE SYSTEM; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; UNCONVENTIONAL T CELL; ANIMAL; ANTIGEN PRESENTATION; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; IMMUNOLOGY; METABOLISM; MOUSE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MICE; MODELS, IMMUNOLOGICAL; MOLECULAR STRUCTURE; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS;

EID: 84944881339     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3298     Document Type: Review

References (159)

1. Lieber M.R. Site-specific recombination in the immune system. FASEB J. 5, 2934-2944 (1991
2. Arstila T.P., et al. A direct estimate of the human alphabeta T cell receptor diversity. Science 286, 958-961 (1999
3. Jenkins M.K., & Moon J.J. The role of naive T cell precursor frequency and recruitment in dictating immune response magnitude. J. Immunol. 188, 4135-4140 (2012
4. Calabi F., Jarvis J.M., Martin L., & Milstein C. Two classes of CD1 genes. Eur. J. Immunol. 19, 285-292 (1989
5. Kasmar A., Van Rhijn I., & Moody D.B. The evolved functions of CD1 during infection. Curr. Opin. Immunol. 21, 397-403 (2009
6. Dougan S.K., Kaser A., & Blumberg R.S. CD1 expression on antigen-presenting cells. Curr. Top. Microbiol. Immunol. 314, 113-141 (2007
7. Van Rhijn I., Godfrey D., Rossjohn J., & Moody D.B. Lipid and small-molecule display by CD1 and MR1. Nat. Rev. Immunol. 15, 643-654 (2015
8. Godfrey D.I., MacDonald H.R., Kronenberg M., Smyth M.J., & Van Kaer L. NKT cells: what's in a name?. Nat. Rev. Immunol. 4, 231-237 (2004
9. Rossjohn J., Pellicci D.G., Patel O., Gapin L., & Godfrey D.I. Recognition of CD1d-restricted antigens by natural killer T cells. Nat. Rev. Immunol. 12, 845-857 (2012
10. Rhost S., Sedimbi S., Kadri N., & Cardell S.L. Immunomodulatory type II natural killer T lymphocytes in health and disease. Scand. J. Immunol. 76, 246-255 (2012
11. Kawano T., et al. Cd1d-restricted and TCR-mediated Activation of V14 NKT cells by glycosylceramides. Science 278, 1626-1629 (1997
12. Cerundolo V., Silk J.D., Masri S.H., & Salio M. Harnessing invariant NKT cells in vaccination strategies. Nat. Rev. Immunol. 9, 28-38 (2009
13. Fujii S.I., et al. NKT cells as an ideal anti-tumor immunotherapeutic. Front. Immunology 4, 409 (2013
14. Hammond K.J.L., et al. CD1d-restricted NKT cells: An interstrain comparison. J. Immunol. 167, 1164-1173 (2001
15. Chan A.C., et al. Ex-vivo analysis of human natural killer T cells demonstrates het-erogeneity between tissues and within established CD4+ and CD4- subsets. Clin. Exp. Immunol. 172, 129-137 (2013
16. Pei B., Vela J.L., Zajonc D., & Kronenberg M. Interplay between carbohydrate and lipid in recognition of glycolipid antigens by natural killer T cells. Ann. NY Acad. Sci. 1253, 68-79 (2012
17. Speak A.O., et al. Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc. Natl. Acad. Sci. USA 104, 5971-5976 (2007
18. Zhou D., et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306, 1786-1789 (2004
19. Brennan P.J., et al. Activation of iNKT cells by a distinct constituent of the endog-enous glucosylceramide fraction. Proc. Natl. Acad. Sci. USA 111, 13433-13438 (2014
20. Kain L., et al. The identification of the endogenous ligands of natural killer T cells reveals the presence of mammalian alpha-linked glycosylceramides. Immunity 41, 543-554 (2014
21. Kain L., et al. Endogenous ligands of natural killer T cells are a-linked glycosylce-ramides. Mol. Immunol. doi: 10.1016/j.molimm.2015.06.009 (30 June2015
22. Wieland Brown L.C., et al. Production of a-galactosylceramide by a prominent mem-ber of the human gut microbiota. PLoS Biol. 11, e1001610 (2013
23. Crowe N.Y., et al. Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. J. Immunol. 171, 4020-4027 (2003
24. Wilson M.T., et al. The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc. Natl. Acad. Sci. USA 100, 10913-10918 (2003
25. Coquet J.M., et al. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population. Proc. Natl. Acad. Sci. USA 105, 11287-11292 (2008
26. Wingender G., Krebs P., Beutler B., & Kronenberg M. Antigen-specific cytotoxic-ity by invariant NKT cells in vivo is CD95/CD178-dependent and is correlated with antigenic potency. J. Immunol. 185, 2721-2729 (2010
27. Vincent M.S., et al. CD1-dependent dendritic cell instruction. Nat. Immunol. 3, 1163-1168 (2002
28. Fujii S., Liu K., Smith C., Bonito A.J., & Steinman R.M. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199, 1607-1618 (2004
29. Eberl G., & MacDonald H.R. Selective induction of NK cell proliferation and cyto-toxicity by activated NKT cells. Eur. J. Immunol. 30, 985-992 (2000
30. Galli G., et al. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J. Exp. Med. 197, 1051-1057 (2003
31. Salio M., Silk J.D., Yvonne Jones E., & Cerundolo V. Biology of CD1- and MR1- restricted T cells. Annu. Rev. Immunol. 32, 323-366 (2014
32. Wu L., & Van Kaer L. Natural killer T cells in health and disease. Front. Biosci. 3, 236-251 (2011
33. De Santo C., et al. Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J. Clin. Invest. 118, 4036-4048 (2008
34. Guillonneau C., et al. Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity. Proc. Natl. Acad. Sci. USA 106, 3330-3335 (2009
35. Chang P.P., et al. Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses. Nat. Immunol. 13, 35-43 (2011
36. Lee Y.J., Holzapfel K.L., Zhu J., Jameson S.C., & Hogquist K.A. Steady-state pro-duction of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat. Immunol. 14, 1146-1154 (2013
37. Michel M.L., et al. Identification of an IL-17-producing NK1.1neg iNKT cell popula-tion involved in airway neutrophilia. J. Exp. Med. 204, 995-1001 (2007
38. Sag D., Krause P., Hedrick C.C., Kronenberg M., & Wingender G. IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset. J. Clin. Invest. 124, 3725-3740 (2014
39. King I.L., et al. Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner. Nat. Immunol. 13, 44-50 (2012
40. Yamasaki K., et al. Induction of NKT cell-specific immune responses in cancer tis-sues after NKT cell-targeted adoptive immunotherapy. Clin. Immunol. 138, 255-265 (2011
41. Schmieg J., Yang G., Franck R.W., & Tsuji M. Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand a-galactosylceramide. J. Exp. Med. 198, 1631-1641 (2003
42. Miyamoto K., Miyake S., & Yamamura T. A synthetic glycolipid prevents autoim-mune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413, 531-534 (2001
43. Bedel R., et al. Lower TCR repertoire diversity in Traj18-deficient mice. Nat. Immunol. 13, 705-706 (2012
44. Chandra S., et al. A new mouse strain for the analysis of invariant NKT cell function. Nat. Immunol. 16, 799-800 (2015
45. Jahng A., et al. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J. Exp. Med. 199, 947-957 (2004
46. Terabe M., et al. A nonclassical non-Va14Ja18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance. J. Exp. Med. 202, 1627-1633 (2005
47. Ambrosino E., et al. Cross-regulation between type I and type II NKT cells in regulat-ing tumor immunity: a new immunoregulatory axis. J. Immunol. 179, 5126-5136 (2007
48. Robertson F.C., Berzofsky J.A., & Terabe M. NKT cell networks in the regulation of tumor immunity. Front. Immunology 5, 543 (2014
49. Chang D.H., et al. Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer. Blood 112, 1308-1316 (2008
50. Tatituri R.V., et al. Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs. Proc. Natl. Acad. Sci. USA 110, 1827-1832 (2013
51. Zeissig S., et al. Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity. Nat. Med. 18, 1060-1068 (2012
52. Van Rhijn I., et al. CD1d-restricted T cell activation by nonlipidic small molecules. Proc. Natl. Acad. Sci. USA 101, 13578-13583 (2004
53. Exley M.A., et al. Cutting edge: A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses. J. Immunol. 167, 5531-5534 (2001
54. de Lalla C., et al. High-frequency and adaptive-like dynamics of human CD1 self-reactive T cells. Eur. J. Immunol. 41, 602-610 (2011
55. Beckman E.M., et al. Recognition of a lipid antigen by CD1-restricted ab+ T cells. Nature 372, 691-694 (1994
56. Van Rhijn I., & Moody D. Donor unrestricted T cells: a shared human T cell response. J. Immunol. 195, 1927-1932 (2015
57. Kasmar A.G., et al. Cutting edge: CD1a tetramers and dextramers identify human lipopeptide-specific T cells ex vivo. J. Immunol. 191, 4499-4503 (2013
58. Kasmar A.G., et al. CD1b tetramers bind ab T cell receptors to identify a mycobacte-rial glycolipid-reactive T cell repertoire in humans. J. Exp. Med. 208, 1741-1747 (2011
59. Ly D., et al. CD1c tetramers detect ex vivo T cell responses to processed phospho-mycoketide antigens. J. Exp. Med. 210, 729-741 (2013
60. Van Rhijn I., et al. A conserved human T cell population targets mycobacterial antigens presented by CD1b. Nat. Immunol. 14, 706-713 (2013
61. Van Rhijn I., et al. TCR bias and affinity define two compartments of the CD1b-glycolipid-specific T cell repertoire. J. Immunol. 192, 4054-4060 (2014
62. Huang S., et al. Discovery of deoxyceramides and diacylglycerols as CD1b scaffold lipids among diverse groove-blocking lipids of the human CD1 system. Proc. Natl. Acad. Sci. USA 108, 19335-19340 (2011
63. van Schaik B., et al. Discovery of invariant T cells by next-generation sequencing of the human TCR a-chain repertoire. J. Immunol. 193, 5338-5344 (2014
64. de Jong A., et al. CD1a-autoreactive T cells are a normal component of the human ab T cell repertoire. Nat. Immunol. 11, 1102-1109 (2010
65. de Jong A., et al. CD1a-autoreactive T cells recognize natural skin oils that function as headless antigens. Nat. Immunol. 15, 177-185 (2014
66. Bourgeois E.A., et al. Bee venom processes human skin lipids for presentation by CD1a. J. Exp. Med. 212, 149-163 (2015
67. Porcelli S., et al. Recognition of cluster of differentiation 1 antigens by human CD4-CD8- cytolytic T lymphocytes. Nature 341, 447-450 (1989
68. Lepore M., et al. A novel self-lipid antigen targets human T cells against CD1c+ leukemias. J. Exp. Med. 211, 1363-1377 (2014
69. Rossjohn J., et al. T cell antigen receptor recognition of antigen-presenting molecules. Annu. Rev. Immunol. 33, 169-200 (2015
70. Treiner E., et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 422, 164-169 (2003
71. Ussher J.E., Klenerman P., & Willberg C.B. Mucosal-associated invariant T-cells: new players in anti-bacterial immunity. Front. Immunol. 5, 450 (2014
72. Reantragoon R., et al. Antigen-loaded MR1 tetramers define T cell receptor heteroge-neity in mucosal-associated invariant T cells. J. Exp. Med. 210, 2305-2320 (2013
73. Gold M.C., et al. MR1-restricted MAIT cells display ligand discrimination and patho-gen selectivity through distinct T cell receptor usage. J. Exp. Med. 211, 1601-1610 (2014
74. Lepore M., et al. Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRb repertoire. Nat. Commun. 5, 3866 (2014
75. Rahimpour A., et al. Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers. J. Exp. Med. 212, 1095-1108 (2015
76. Dusseaux M., et al. Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 117, 1250-1259 (2011
77. Le Bourhis L., et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat. Immunol. 11, 701-708 (2010
78. Gold M.C., et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol. 8, e1000407 (2010
79. Corbett A.J., et al. T-cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature 509, 361-365 (2014
80. Eckle S.B., et al. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells. J. Exp. Med. 211, 1585-1600 (2014
81. Kjer-Nielsen L., et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491, 717-723 (2012
82. Patel O., et al. Recognition of vitamin B metabolites by mucosal-associated invariant T cells. Nat. Commun. 4, 2142 (2013
83. Soudais C., et al. In vitro and in vivo analysis of the Gram-negative bacteria-derived riboflavin precursor derivatives activating mouse MAIT Cells. J. Immunol. 194, 4641-4649 (2015
84. Meierovics A., Yankelevich W.J., & Cowley S.C. MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection. Proc. Natl. Acad. Sci. USA 110, E3119-E3128 (2013
85. Leeansyah E., et al. Activation, exhaustion, and persistent decline of the antimi-crobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood 121, 1124-1135 (2013
86. Fernandez C.S., et al. MAIT cells are depleted early but retain functional cytokine expression in HIV infection. Immunol. Cell Biol. 93, 177-188 (2015
87. Leeansyah E., et al. Arming of MAIT cell cytolytic antimicrobial activity is induced by IL-7 and defective in HIV-1 infection. PLoS Pathog. 11, e1005072 (2015
88. Ussher J.E., et al. CD161++ CD8+ T cells, including the MAIT cell subset, are specifi-cally activated by IL-12+IL-18 in a TCR-independent manner. Eur. J. Immunol. 44, 195-203 (2014
89. Croxford J.L., Miyake S., Huang Y.Y., Shimamura M., & Yamamura T. Invariant V19i T cells regulate autoimmune inflammation. Nat. Immunol. 7, 987-994 (2006
90. Serriari N.E., et al. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. Clin. Exp. Immunol. 176, 266-274 (2014
91. Magalhaes I., et al. Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. J. Clin. Invest. 125, 1752-1762 (2015
92. Teunissen M.B., et al. The IL-17A-producing CD8 T cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells. J. Invest. Dermatol. 134, 2898-2907 (2014
93. Cho Y.N., et al. Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus. J. Immunol. 193, 3891-3901 (2014
94. Smith D.J., Hill G.R., Bell S.C., & Reid D.W. Reduced mucosal associated invariant T-cells are associated with increased disease severity and Pseudomonas aeruginosa infection in cystic fibrosis. PLoS ONE 9, e109891 (2014
95. Chien Y.H., Meyer C., & Bonneville M. gammadelta T cells: first line of defense and beyond. Annu. Rev. Immunol. 32, 121-155 (2014
96. Vantourout P., & Hayday A. Six-of-the-best: unique contributions of gd T cells to immunology. Nat. Rev. Immunol. 13, 88-100 (2013
97. Rock E.P., Sibbald P.R., Davis M.M., & Chien Y.H. CDR3 length in antigen-specific immune receptors. J. Exp. Med. 179, 323-328 (1994
98. O'Brien R.L., & Born W.K. Dermal gd T cells-What have we learned?. Cell. Immunol. 296, 62-69 (2015
99. Takagaki Y., DeCloux A., Bonneville M., & Tonegawa S. Diversity of gd T-cell recep-tors on murine intestinal intra-epithelial lymphocytes. Nature 339, 712-714 (1989
100. Pereira P., Lafaille J.J., Gerber D., & Tonegawa S. The T cell receptor repertoire of intestinal intraepithelial gd T lymphocytes is influenced by genes linked to the major histocompatibility complex and to the T cell receptor loci. Proc. Natl. Acad. Sci. USA 94, 5761-5766 (1997
101. Gerber D.J., et al. IL4-producing gd T cells that express a very restricted TCR reper-toire are preferentially localized in liver and spleen. J. Immunol. 163, 3076-3082 (1999
102. Sim G.K., Rajaserkar R., Dessing M., & Augustin A. Homing and in situ differentia-tion of resident pulmonary lymphocytes. Int. Immunol. 6, 1287-1295 (1994
103. Itohara S., et al. Homing of a gd thymocyte subset with homogeneous T-cell receptors to mucosal epithelia. Nature 343, 754-757 (1990
104. O'Brien R.L., & Born W.K. gd T cell subsets: a link between TCR and function?. Semin. Immunol. 22, 193-198 (2010
105. Ebert L.M., Meuter S., & Moser B. Homing and function of human skin T cells and NK cells: relevance for tumor surveillance. J. Immunol. 176, 4331-4336 (2006
106. Toulon A., et al. A role for human skin-resident T cells in wound healing. J. Exp. Med. 206, 743-750 (2009
107. Deusch K., et al. A major fraction of human intraepithelial lymphocytes simultane-ously expresses the gd T cell receptor, the CD8 accessory molecule and preferentially uses the V1 gene segment. Eur. J. Immunol. 21, 1053-1059 (1991
108. Karunakaran M.M., Gobel T.W., Starick L., Walter L., & Herrmann T. V9 and V2 T cell antigen receptor genes and butyrophilin 3 (BTN3) emerged with placental mammals and are concomitantly preserved in selected species like alpaca (Vicugna pacos). Immunogenetics 66, 243-254 (2014
109. Hintz M., et al. Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human gd T cells in Escherichia coli. FEBS Lett. 509, 317-322 (2001
110. Gu S., Nawrocka W., & Adams E.J. Sensing of pyrophosphate metabolites by V9V2 T cells. Front. Immunol. 5, 688 (2014
111. Bukowski J.F., Morita C.T., & Brenner M.B. Human gd T cells recognize alkylamines derived from microbes, edible plants, and tea: implications for innate immunity. Immunity 11, 57-65 (1999
112. Tanaka Y., et al. Natural and synthetic non-peptide antigens recognized by human gd T cells. Nature 375, 155-158 (1995
113. Li H., et al. Structure of the V domain of a human gd T-cell antigen receptor. Nature 391, 502-506 (1998
114. Allison T.J., Winter C.C., Fournie J.J., Bonneville M., & Garboczi D.N. Structure of a human gd T-cell antigen receptor. Nature 411, 820-824 (2001
115. Vavassori S., et al. Butyrophilin 3A1 binds phosphorylated antigens and stimulates human gd T cells. Nat. Immunol. 14, 908-916 (2013
116. Sandstrom A., et al. The intracellular B30.2 domain of butyrophilin 3A1 binds phos-phoantigens to mediate activation of human V9V2 T cells. Immunity 40, 490-500 (2014
117. Rhodes D.A., et al. Activation of human gd T cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin. J. Immunol. 194, 2390-2398 (2015
118. Willcox C.R., et al. Cytomegalovirus and tumor stress surveillance by binding of a human gd T cell antigen receptor to endothelial protein C receptor. Nat. Immunol. 13, 872-879 (2012
119. Spada F.M., et al. Self-recognition of CD1 by gd T cells: implications for innate immunity. J. Exp. Med. 191, 937-948 (2000
120. Uldrich A.P., et al. CD1d-lipid antigen recognition by the gd TCR. Nat. Immunol. 14, 1137-1145 (2013
121. Bai L., et al. The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant V1 TCR. Eur. J. Immunol. 42, 2505-2510 (2012
122. Wu J., Groh V., & Spies T. T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial gd T cells. J. Immunol. 169, 1236-1240 (2002
123. Kong Y., et al. The NKG2D ligand ULBP4 binds to TCRg9/d2 and induces cytotoxicity to tumor cells through both TCRgd and NKG2D. Blood 114, 310-317 (2009
124. Luoma A.M., et al. Crystal structure of Vdelta1 T cell receptor in complex with CD1d-sulfatide shows MHC-like recognition of a self-lipid by human gd T cells. Immunity 39, 1032-1042 (2013
125. Agea E., et al. Human CD1-restricted T cell recognition of lipids from pollens. J. Exp. Med. 202, 295-308 (2005
126. Russano A.M., et al. Recognition of pollen-derived phosphatidyl-ethanolamine by human CD1d-restricted gd T cells. J. Allergy Clin. Immunol. 117, 1178-1184 (2006
127. Mangan B.A., et al. Cutting edge: CD1d restriction and th1/th2/th17 cytokine secre-tion by human Vd3 T cells. J. Immunol. 191, 30-34 (2013
128. Zeng X., et al. gd T cells recognize a microbial encoded B cell antigen to initiate a rapid antigen-specific interleukin-17 response. Immunity 37, 524-534 (2012
129. Bruder J., et al. Target specificity of an autoreactive pathogenic human gd-T cell receptor in myositis. J. Biol. Chem. 287, 20986-20995 (2012
130. Rodgers J.R., & Cook R.G. MHC class Ib molecules bridge innate and acquired immunity. Nat. Rev. Immunol. 5, 459-471 (2005
131. Sullivan L.C., Clements C.S., Rossjohn J., & Brooks A.G. The major histocompat-ibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity. Tissue Antigens 72, 415-424 (2008
132. Barakonyi A., et al. Recognition of nonclassical HLA class I antigens by gd T cells during pregnancy. J. Immunol. 168, 2683-2688 (2002
133. Cho H., Choi H.-J., Xu H., Felio K., & Wang C.-R. Nonconventional CD8+ T cell responses to listeria infection in mice lacking MHC class Ia and H2-M3. J. Immunol. 186, 489-498 (2011
134. Caccamo N., et al. Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines. Eur. J. Immunol. 45, 1069-1081 (2015
135. van Meijgaarden K.E., et al. Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2- like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset. PLoS Pathog. 11, e1004671 (2015
136. Sullivan L.C., Hoare H.L., McCluskey J., Rossjohn J., & Brooks A.G. A structural perspective on MHC class Ib molecules in adaptive immunity. Trends Immunol. 27, 413-420 (2006
137. Chiu N.M., et al. The selection of M3-restricted T cells is dependent on M3 expres-sion and presentation of N-formylated peptides in the thymus. J. Exp. Med. 190, 1869-1878 (1999
138. Swanson P.A., et al. An MHC class Ib-restricted CD8 T cell response confers antiviral immunity. J. Exp. Med. 205, 1647-1657 (2008
139. Chiang E.Y., & Stroynowski I. Protective immunity against disparate tumors is medi-ated by a nonpolymorphic MHC class I molecule. J. Immunol. 174, 5367-5374 (2005
140. Hofstetter A.R., et al. MHC class Ib-restricted CD8 T cells differ in dependence on CD4 T cell Help and CD28 costimulation over the course of mouse polyomavirus infection. J. Immunol. 188, 3071-3079 (2012
141. Rohrlich P.S., et al. Direct recognition by ab cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting function. Proc. Natl. Acad. Sci. USA 102, 12855-12860 (2005
142. Crowley M.P., et al. A population of murine gd T cells that recognize an inducible MHC class Ib molecule. Science 287, 314-316 (2000
143. Crowley M.P., Reich Z., Mavaddat N., Altman J.D., & Chien Y. The recognition of the nonclassical major histocompatibility complex (MHC) class I molecule, T10, by the gd T cell, G8. J. Exp. Med. 185, 1223-1230 (1997
144. Tefit J.N., et al. Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination. Vaccine 32, 6138-6145 (2014
145. Gomes A.Q., Martins D.S., & Silva-Santos B. Targeting gd T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application. Cancer Res. 70, 10024-10027 (2010
146. Birkinshaw R.W., et al. ab T cell antigen receptor recognition of CD1a presenting self lipid ligands. Nat. Immunol. 16, 258-266 (2015
147. Tefit J.N., Davies G., & Serra V. NKT cell responses to glycolipid activation. Methods Mol. Biol. 626, 149-167 (2010
148. Shimizu K., Kurosawa Y., Taniguchi M., Steinman R.M., & Fujii S. Cross-presentation of glycolipid from tumor cells loaded with a-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells. J. Exp. Med. 204, 2641-2653 (2007
149. Venkataswamy M.M., et al. Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette- Guerin. J. Immunol. 183, 1644-1656 (2009
150. Melero I., et al. Evolving synergistic combinations of targeted immunotherapies to combat cancer. Nat. Rev. Cancer 15, 457-472 (2015
151. Pardoll D.M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252-264 (2012
152. Dupuy P., et al. T-cell receptor-gd bearing lymphocytes in normal and inflammatory human skin. J. Invest. Dermatol. 94, 764-768 (1990
153. Felio K., et al. CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice. J. Exp. Med. 206, 2497-2509 (2009
154. Lockridge J.L., et al. Analysis of the CD1 antigen presenting system in humanized SCID mice. PLoS ONE 6, e21701 (2011
155. Dascher C.C., et al. Conservation of a CD1 multigene family in the guinea pig. J. Immunol. 163, 5478-5488 (1999
156. Kasmar A.G., et al. CD1b tetramers bind ab T cell receptors to identify a mycobacterial glycolipid-reactive T cell repertoire in humans. J. Exp. Med. 208, 1741-1747 (2011
157. Ly D., et al. CD1c tetramers detect ex vivo T cell responses to processed phospho-mycoketide antigens. J. Exp. Med. 210, 729-741 (2013
158. Berzins S.P., Cochrane A.D., Pellicci D.G., Smyth M.J., & Godfrey D.I. Limited cor-relation between human thymus and blood NKT cell content revealed by an ontogeny study of paired tissue samples. Eur. J. Immunol. 35, 1399-1407 (2005
159. Matsuda J.L., et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192, 741-754 (2000